Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
CONTEXT: Previous research has suggested that activation of the renin-angiotensin-aldosterone system may promote insulin resistance and β-cell dysfunction, but the association with incident diabetes in African Americans is unknown. OBJECTIVE: We examined the association of aldosterone and renin with insulin resistance, β-cell function, and incident diabetes in a large African American cohort. DESIGN: The Jackson Heart Study is a prospective study of the development and progression of cardiovascular disease in African Americans. SETTING: Participants were recruited from the tricounty area of metropolitan Jackson, Mississippi. PARTICIPANTS: A total of 5301 African American adults, aged 21–94 years, were assessed at baseline and through 12 years of follow-up. Data on aldosterone, renin, and risk factors were collected at baseline (2000–2004). Diabetes (fasting glucose ≥ 126 mg/dL, physician diagnosis, use of diabetes drugs, or glycated hemoglobin ≥ 6.5%) was assessed at baseline and through 12 years of follow-up. Participants were excluded for missing data on baseline covariates or diabetes follow-up. Cox regression was used to estimate hazard ratios (HR) for incident diabetes using sequential modeling adjusting for age, sex, education, occupation, systolic blood pressure, current smoking, physical activity, dietary intake, and body mass index. EXPOSURES: Aldosterone, renin, and diabetes risk factors were measured. OUTCOME: Outcomes included the homeostatic model assessment of insulin resistance (HOMA-IR) and incident diabetes. RESULTS: Among 3234 participants over a median of 8.0 years of follow-up, there were 554 cases of incident diabetes. Every 1% increase in log-transformed aldosterone was associated with a 0.18% higher log-transformed HOMA-IR in cross-sectional analyses of nondiabetic participants (P < .001). Log-transformed aldosterone and renin levels in the fifth vs first quintile were associated with a 78% (HR 1.78, 95% confidence interval 1.35–2.34) and 35% (HR 1.35, 95% confidence interval 1.06–1.72) increase in diabetes risk, respectively, in fully adjusted models. CONCLUSIONS: Activation of the renin-angiotensin-aldosterone system may play a significant role in the development of insulin resistance and diabetes in African Americans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary aldosteronism is also associated with glucose intolerance and an increased risk of type 2 diabetes (2–4)”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750 · cited 2×
“Physical activity was defined according to the American Heart Association (AHA) categorization (17) as poor health (0 min of moderate and vigorous activity), intermediate health ( 0 min but 150 min of moderate activity), 0 min but 75 min of vigorous activity, or 0 min but 150 min of combined moderate and vigorous acti…”
MethodGeiss, L. S., Wang, J., Cheng, Y. J., Thompson, T. J., Barker, L., Li, Y., Albright, A. L., & Gregg, E. W. (2014) · JAMA · doi:10.1001/jama.2014.11494 · Cited by 672
Effect of valsartan on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001121 · Cited by 660 · cited 1×
“The two major trials of RAAS inhibition and incident diabetes, The Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication (DREAM) study (32) and the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcome Research (NAVIGATOR) study (33) revealed conflicting findings in majority NHW population…”
BackgroundRace/Ethnic Difference in Diabetes and Diabetic Complications
Spanakis, E. K., & Golden, S. H. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0421-9 · Cited by 632 · cited 1×
“Type 2 diabetes mellitus (diabetes) is more prevalent among African Americans (AAs) than among nonHispanic whites (NHWs) (1, 2) and is associated with a 50%–100% higher morbidity and mortality (2, 3).”
BackgroundSelf-citationTaylor, H. A., WILSON, J. G., Jones, D. W., Sarpong, D. F., Srinivasan, A., Garrison, R. J., Nelson, C. R., & Wyatt, S. B. (2005) · PubMed · Cited by 584
Golden, S. H., Brown, A., Cauley, J. A., Chin, M. H., Gary-Webb, T. L., Kim, C., Sosa, J. A., Sumner, A. E., & Anton, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2043 · Cited by 405 · cited 1×
“Type 2 diabetes mellitus (diabetes) is more prevalent among African Americans (AAs) than among nonHispanic whites (NHWs) (1, 2) and is associated with a 50%–100% higher morbidity and mortality (2, 3).”
BackgroundSelf-citationBriones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190223 · Cited by 375 · cited 2×
“The aforementioned interaction between aldosterone and adipocyte differentiation is important because adipocytes possess aldosterone synthase and produce aldosterone independent of the adrenal gland (24).”
Background
Cited by
Gillespie, S. L., Anderson, C. M., Zhao, S., Tan, Y., Kline, D., Brock, G., Odei, J., O’Brien, E., Sims, M., Lazarus, S. A., et al. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.06.020 · Cited by 81
“HbA1c concentrations were measured as previously described (Joseph et al., 2016).”
MethodSelf-citationOrtiz, R., Kluwe, B., Odei, J. B., Echouffo Tcheugui, J. B., Sims, M., Kalyani, R. R., Bertoni, A. G., Golden, S. H., & Joseph, J. J. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.12.237 · Cited by 76
Self-citationRenin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA
Joseph, J. J., Echouffo-Tcheugui, J. B., Effoe, V. S., Hsueh, W. A., Allison, M., & Golden, S. H. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009890 · Cited by 76
“We have previously shown a dose-response relationship between aldosterone and incident type 2 diabetes mellitus among blacks.(6) In MESA, blacks had the lowest serum aldosterone compared with the other racial/ethnic groups, but importantly, the level may be less critical than the post-receptor signaling cascade evoked…”
BackgroundSelf-citationPrimary aldosteronism decreases insulin secretion and increases insulin clearance in humans
Adler, G. K., Murray, G. R., Turcu, A. F., Nian, H., Yu, C., Solorzano, C. C., Manning, R., Peng, D., & Luther, J. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13922 · Cited by 71
Spahillari, A., Talegawkar, S., Correa, A., Carr, J. J., Terry, J. G., Lima, J., Freedman, J. E., Das, S., Kociol, R., de Ferranti, S., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003682 · Cited by 68
Self-citationJoseph, J. J., Rajwani, A., Roper, D., Zhao, S., Kline, D., Odei, J. B., Brock, G. N., Echouffo-Tcheugui, J. B., Kalyani, R. R., Bertoni, A. G., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.38361 · Cited by 64
Self-citationFaulkner, J., Harwood, D., Bender, L., Shrestha, L., Brands, M. W., Morwitzer, M. J., Kennard, S., Antonova, G. N., & de Chantemèle, E. J. B. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11303 · Cited by 58
Joseph, J. J., Bennett, A., Echouffo Tcheugui, J. B., Effoe, V. S., Odei, J. B., Hidalgo, B., Dulin, A., Safford, M. M., Cummings, D. M., Cushman, M., et al. (2019) · Diabetologia · doi:10.1007/s00125-018-4792-y · Cited by 54
Self-citationJoseph, J. J., Pohlman, N. K., Zhao, S., Kline, D., Brock, G., Echouffo-Tcheugui, J. B., Sims, M., Effoe, V. S., Wu, W.-C., Kalyani, R. R., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050896 · Cited by 51
“Male 283 (31) 65 (27) 83 (36) 80 (35) 55 (25)”
Self-citationAldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans
Joseph, J. J., Echouffo-Tcheugui, J. B., Kalyani, R. R., Yeh, H., Bertoni, A. G., Effoe, V. S., Casanova, R., Sims, M., Wu, W.-C., Wand, G. S., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.05.012 · Cited by 41
“Based on prior analyses, covariates were selected a priori (10,20), multivariate modeling was performed with sequential adjustment as follows:”
InfluentialSelf-citationvan Rooyen, J., Poglitsch, M., Huisman, H., Mels, C., Kruger, R., Malan, L., Botha, S., Lammertyn, L., Gafane, L., & Schutte, A. (2016) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320316669880 · Cited by 39
The Person’s Care Requires a Sex and Gender Approach
Campesi, I., Montella, A., Seghieri, G., & Franconi, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204770 · Cited by 27
Kesireddy, V., Tan, Y., Kline, D., Brock, G. N., Odei, J. B., Kluwe, B., Effoe, V. S., Echouffo-Tcheugui, J. B., Kalyani, R. R., Sims, M., et al. (2019) · Nutrients · doi:10.3390/nu11050955 · Cited by 23
“5 grams per day [5], much closer to the high-salt diet in the study, and thus our finding of higher aldosterone in men is consistent with this study, but does not explain the greater magnitude of association of higher LS7 score with lower aldosterone among women.”
BackgroundMethodResultSelf-citationPollard, J. D., Haq, K. T., Lutz, K. J., Rogovoy, N. M., Paternostro, K. A., Soliman, E. Z., Maher, J., Lima, J. A. C., Musani, S. K., & Tereshchenko, L. G. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab003 · Cited by 24
The mineralocorticoid receptor in diabetic kidney disease
Jia, G., Lastra, G., Bostick, B. P., Laham-Karam, N., Laakkonen, J. P., Ylä‐Herttuala, S., & Whaley‐Connell, A. T. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00135.2024 · Cited by 23
Clemmer, J. S., Faulkner, J., Mullen, A. J., Butler, K. R., & Hester, R. L. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0238-6 · Cited by 16
Obesity and the diagnostic accuracy for primary aldosteronism
Tirosh, A., Hannah‐Shmouni, F., Lyssikatos, C., Belyavskaya, E., Zilbermint, M. F., Abraham, S. B., Lodish, M. B., & Stratakis, C. A. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13041 · Cited by 17
Min, S. H., Kong, S. H., Lee, J.-E., Lee, D., Oh, T. J., Kim, K. M., Park, K. S., Jang, H. C., & Lim, S. K. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.07.002 · Cited by 15
“Recently, in a large African-American cohort study, higher renin levels were associatedwith both a greater prevalence and a higher incidence of diabetes.(34) Therefore, high renin levels are also likely to contribute to development of diabetic complications.”
BackgroundChatterjee, R., Davenport, C. A., Svetkey, L. P., Batch, B. C., Lin, P., Vasan, R. S., Fox, E. R., Harman, J. L., Yeh, H., Selvin, E., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.143255 · Cited by 15
Self-citationJoseph, J. J., Zhou, X., Zilbermint, M. F., Stratakis, C. A., Faucz, F. R., Lodish, M. B., Berthon, A. S., Wilson, J. G., Hsueh, W. A., Golden, S. H., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa290 · Cited by 17
Self-citationHuman Genome Evolution and Development of Cardiovascular Risk Factors Through Natural Selection
Poledne, R., & Zicha, J. (2018) · Physiological Research · doi:10.33549/physiolres.933885 · Cited by 11
Wang, J., Hu, H., Song, J., Yan, F., Qin, J., Guo, X., Cui, C., He, Q., Hou, X., Liu, F., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.149 · Cited by 11
Kesireddy, V., Kluwe, B., Pohlman, N., Zhao, S., Tan, Y., Kline, D., Brock, G. N., Odei, J. B., Effoe, V. S., Echouffo-Tcheugui, J. B., et al. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100466 · Cited by 10
“7 the primary mediation analysis, BP and glucose were excluded due to the known effect of aldosterone increasing BP and altering glucose [3].”
BackgroundSelf-citationThe association of serum vitamin D with incident diabetes in an African American population
Joseph, J. J., Langan, S. J., Lunyera, J., Kluwe, B., Williams, A., Chen, H., Sachs, M. C., Hairston, K. G., Bertoni, A. G., Hsueh, W. A., et al. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00220-4 · Cited by 9
“Serum aldosterone was measured by radioimmunoassay (Siemens) and the intraassay coefficients of variation are reported elsewhere [28].”
BackgroundMethodSelf-citationAgoons, D. D., Musani, S. K., Correa, A., Golden, S. H., Bertoni, A. G., & Echouffo-Tcheugui, J. B. (2022) · Diabetic Medicine · doi:10.1111/dme.14895 · Cited by 11
Self-citationThen, C., Ritzel, K., Herder, C., Then, H. L., Sujana, C., Heier, M., Meisinger, C., Peters, A., Köenig, W., Rathmann, W., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002558 · Cited by 9
“44 Therefore, RAAS-dependent and independent effects of dietary sodium on glucose metabolism cannot be excluded.”
BackgroundZhao, D., Cao, Y., Yu, C., Yuan, S., Zhang, N., Zhang, Y., Staessen, J. A., & Feng, Y. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13517 · Cited by 10
Diabetes and Renin-Angiotensin-Aldosterone System: Pathophysiology and Genetics
Nabi, A. H. M. N., & Ebihara, A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97518 · Cited by 13
Tse, L.-S., Liao, P.-L., Tsai, C.-H., Li, C.-H., Liao, J., Kang, J., & Cheng, Y. (2019) · Nutrients · doi:10.3390/nu11030629 · Cited by 10
“An increase in aldosterone causes impaired glucose tolerance, decreased pancreatic β-cell function, and tissue insulin sensitivity [31,34,35].”
BackgroundChen, U.-L., Liao, C., Wang, S., Lai, T., Huang, K., Chang, C., Lee, B., Lu, C., Chang, Y., Chang, Y., et al. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589221141840 · Cited by 7
The Role of High Salt Intake in the Development and Progression of Diverse Diseases
Kompanowska‐Jezierska, E., & Olszyński, K. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811442-1.00013-4 · Cited by 8
Yang, Y., Lim, M. H., Lee, S. O., Roh, E., Ahn, C. H., Kwak, S. H., Cho, Y. M., Kim, S., Mari, A., Park, K. S., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13282 · Cited by 7
“Activation of the renin-angiotensin system (RAS) has been suggested to be involved in the pathogenesis of type 2 diabetes and associated complications.(1,2) The use of angiotensin receptor blockers (ARBs) or angiotensin-converting enzyme (ACE) inhibitors, which are pharmacological interventions blocking the RAS, is re…”
BackgroundPollard, J. D., Haq, K. T., Lutz, K. J., Rogovoy, N. M., Paternostro, K. A., Soliman, E. Z., Maher, J., Lima, J. A. C., Musani, S. K., & Tereshchenko, L. G. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-042899 · Cited by 6
Adiposity, aldosterone and plasma renin activity among African Americans: The Jackson Heart Study
Lee, G., Kluwe, B., Zhao, S., Kline, D., Nedungadi, D., Brock, G. N., Odei, J. B., Kesireddy, V., Pohlman, N., Sims, M., et al. (2023) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2023.100126 · Cited by 6
Self-citationWang, N., Li, J., Tian, E., Li, S., Liu, S., Cao, F., Kong, J., & Yue, B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316049 · Cited by 9
“Studies have demonstrated that aldosterone (ALD) can impede insulin secretion and sensitivity, which are pivotal elements in the progression of T2DM [9,14].”
Screening for primary aldosteronism in the diabetic population: a cohort study
Tan, S. J., Libianto, R., Yang, J., & Wong, J. (2022) · Internal Medicine Journal · doi:10.1111/imj.15690 · Cited by 5
Mineralocorticoids, glucose homeostasis and type 2 diabetes mellitus: The Henan Rural Cohort study
Wei, D., Liu, X., Jiang, J., Tu, R., Qiao, D., Li, R., Wang, Y., Fan, M., Yang, X., Zhang, J., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107558 · Cited by 5
Zhang, C., Jiang, Y., Su, T., Jiang, L., Zhou, W., Zhong, X., Wu, L., & Wang, W. (2022) · Endocrine · doi:10.1007/s12020-022-03095-8 · Cited by 4
Nedungadi, D., Adesanya, T. M. A., Rayan, M. N., Zhao, S., Williams, A., Brock, G. N., & Joseph, J. J. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae396 · Cited by 4
Self-citationGlucometabolic State Transitions: The Jackson Heart Study
Gaillard, T. R., Chen, H., Effoe, V. S., Correa, A., Carnethon, M. R., Kalyani, R. R., Echouffo-Tcheugui, J. B., Joseph, J. J., & Bertoni, A. G. (2022) · Ethnicity & Disease · doi:10.18865/ed.32.3.203 · Cited by 3
Self-citationKluwe, B., Pohlman, N., Kesireddy, V., Zhao, S., Tan, Y., Kline, D., Brock, G. N., Odei, J. B., Effoe, V. S., Echouffo-Tcheugui, J. B., et al. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100494 · Cited by 4
“We have previously reported that higher aldosterone is associated with increased incidence of CVD and all-cause mortality in AAs [9,10].”
BackgroundInfluentialSelf-citationJoseph, J. J., Kluwe, B., Zhao, S., Kline, D., Nedungadi, D., Brock, G. N., Hsueh, W. A., & Golden, S. H. (2023) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2023.100128 · Cited by 2
Self-citationLi, X., Heizhati, M., Li, M., Yao, L., Wu, T., Yang, W., Gan, L., Wang, H., Liu, M., Maitituersun, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-91538-3 · Cited by 3
Yeboah, F. A., Nkum, B. C., Amankwaa, B., Eghan, B., Acheampong, E., Nsiah, P., Okyere, P., Owusu, L., Batu, E. N., & Anto, E. O. (2017) · OALib · doi:10.4236/oalib.1103952
Зиявдинович, С. М., Маммаев, С. Н., Magadova, G. M., Баламирзоева, Р. М., Magomedova, Z. S., Магомедова, З. С., & Гамзаева, А. У. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4549 · Cited by 1
Ahmed, S., Anirban, P., & Lawrence, A. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3603361 · Cited by 1
Research Progress on Related Factors Affecting Elevated Aldosterone Levels
阿达莱提, ·. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122750
Wang, N., Kong, J., Lu, Z., Cao, F., Tian, E., Li, J., Li, S., Liu, S., & Yue, B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336158
“Several studies not addressing SGLT-2is have demonstrated that RAAS activation was associated with glucose metabolic abnormalities [18], insulin resistance [21], and impaired renal function [19,20].”
Parati, G., Ogedegbe, G. G., Agiro, A., Luan, S., Davis, H., Daniel, I., McKendrick, J., Huang, J. Y., & Townsend, R. R. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03530-6
“Higher aldosterone (serum aldosterone, ARR) has been associated with insulin resistance, increased risk of diabetes, and worse outcomes (diabetic nephropathy) in patients with diabetes (four articles) [46, 61, 90, 92].”
Afşar, B., Kanbay, M., & Afşar, R. E. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106674
Sánchez‐Bayuela, T., Barrera‐Chimal, J., & Jaisser, F. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01125-6 · Cited by 1
Metadata
- Authors
- Joseph, J. J., Echouffo-Tcheugui, J. B., Kalyani, R. R., Yeh, H.-C., Bertoni, A. G., Effoe, V. S., Casanova, R., Sims, M., Correa, A., Wu, W.-C., Wand, G. S., & Golden, S. H.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Golden, Sherita H.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-04
- Volume
- 101
- Issue
- 4
- Pages
- 1770-1778
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4880170
- OpenAlex
- W2279370417
- Semantic Scholar
- 07ef68cf193425df39e894c88c2df56bf59c7687
- Cited by
- 51
- References
- 42
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 7 · 2021: 6 · 2020: 4 · 2019: 7 · 2018: 6 · 2017: 5 · 2016: 2
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HHSN268201300050C, HHSN268201300046C, HHSN268201300048C, HHSN268201300049C, HHSN268201300047C)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK062707)
- National Institute on Minority Health and Health Disparities
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- aldosterone, renin, renin-angiotensin-aldosterone system, diabetes mellitus, new-onset diabetes, insulin resistance, beta-cell function, African Americans, HOMA-IR, cardiovascular risk, Jackson Heart Study, obesity, smoking, physical activity, dietary intake, HbA1c, fasting blood glucose, cardiovascular risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aldosterone, Black or African American, Blood Pressure, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Insulin Resistance, Male, Middle Aged, Renin, Renin-Angiotensin System, Risk Factors, Body Mass Index, Insulin-Secreting Cells, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.